This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Feb;38(2):723-4.

doi: 10.1097/CCM.0b013e3181bc80b9.

COX2 inhibitors for acquired brain injuries: is the time ripe?

Kenneth I Strauss

PMID: 20083946
PMCID: PMC3313841
DOI: 10.1097/CCM.0b013e3181bc80b9

Editorial

COX2 inhibitors for acquired brain injuries: is the time ripe?

Kenneth I Strauss. Crit Care Med. 2010 Feb.

. 2010 Feb;38(2):723-4.

doi: 10.1097/CCM.0b013e3181bc80b9.

Author

Kenneth I Strauss

PMID: 20083946
PMCID: PMC3313841
DOI: 10.1097/CCM.0b013e3181bc80b9

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author has not disclosed any potential conflicts of interest.

Comment on

Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.
Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, Zhang JH. Fathali N, et al. Crit Care Med. 2010 Feb;38(2):572-8. doi: 10.1097/CCM.0b013e3181cb1158. Crit Care Med. 2010. PMID: 20029340 Free PMC article.

Similar articles

Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.
Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, Zhang JH. Fathali N, et al. Crit Care Med. 2010 Feb;38(2):572-8. doi: 10.1097/CCM.0b013e3181cb1158. Crit Care Med. 2010. PMID: 20029340 Free PMC article.
Chronic inhibition of cyclooxygenase-2 induces dendritic hypertrophy and limited functional improvement following motor cortex stroke.
Silasi G, Kolb B. Silasi G, et al. Neuroscience. 2007 Feb 23;144(4):1160-8. doi: 10.1016/j.neuroscience.2006.10.030. Epub 2006 Dec 15. Neuroscience. 2007. PMID: 17175107
NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice.
Stachowicz K, Bobula B, Tokarski K. Stachowicz K, et al. Brain Res. 2020 May 1;1734:146741. doi: 10.1016/j.brainres.2020.146741. Epub 2020 Feb 20. Brain Res. 2020. PMID: 32088181
The use of nimesulide and its analogues in cancer chemoprevention.
Renard JF, Julémont F, de Leval X, Pirotte B. Renard JF, et al. Anticancer Agents Med Chem. 2006 May;6(3):233-7. doi: 10.2174/187152006776930855. Anticancer Agents Med Chem. 2006. PMID: 16712451 Review.
Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.
Strauss KI. Strauss KI. Brain Behav Immun. 2008 Mar;22(3):285-98. doi: 10.1016/j.bbi.2007.09.011. Epub 2007 Nov 8. Brain Behav Immun. 2008. PMID: 17996418 Free PMC article. Review.

See all similar articles

Cited by

Using anesthetics and analgesics in experimental traumatic brain injury.
Rowe RK, Harrison JL, Thomas TC, Pauly JR, Adelson PD, Lifshitz J. Rowe RK, et al. Lab Anim (NY). 2013 Aug;42(8):286-91. doi: 10.1038/laban.257. Lab Anim (NY). 2013. PMID: 23877609 Free PMC article. Review.
Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge.
An Y, Belevych N, Wang Y, Zhang H, Herschman H, Chen Q, Quan N. An Y, et al. J Neurosci Res. 2014 Apr;92(4):486-95. doi: 10.1002/jnr.23317. Epub 2013 Dec 24. J Neurosci Res. 2014. PMID: 24375716 Free PMC article.
Strategies to defeat ketamine-induced neonatal brain injury.
Turner CP, Gutierrez S, Liu C, Miller L, Chou J, Finucane B, Carnes A, Kim J, Shing E, Haddad T, Phillips A. Turner CP, et al. Neuroscience. 2012 May 17;210:384-92. doi: 10.1016/j.neuroscience.2012.02.015. Epub 2012 Feb 23. Neuroscience. 2012. PMID: 22406413 Free PMC article.
Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review.
Frank D, Gruenbaum BF, Zlotnik A, Semyonov M, Frenkel A, Boyko M. Frank D, et al. Int J Mol Sci. 2022 Dec 1;23(23):15114. doi: 10.3390/ijms232315114. Int J Mol Sci. 2022. PMID: 36499434 Free PMC article. Review.

References

1. Fathali N, Ostrowski RP, Lekic T, et al. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med. 2010;38:572–578. - PMC - PubMed
1. Strauss KI. Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav Immun. 2008;22:285–298. - PMC - PubMed
1. Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebro-spinal fluid after severe traumatic brain injury in children. J Neurotrauma. 1997;14:451–457. - PubMed
1. Blom MA, van Twillert MG, de Vries SC, et al. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: The involvement of prostaglandin E2. Brain Research. 1997;777:210–218. - PubMed
1. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004;63:901–910. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 NS054890/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program